165
Participants
Start Date
June 6, 2022
Primary Completion Date
June 30, 2024
Study Completion Date
August 31, 2024
rhTPO
rhTPO 300U/kg/d QD, subcutaneous injection applied for 5 days per cycle, total 3 cycles. If the patient's platelet count showed a trend of continuous decline and/or was accompanied by the risk of bleeding during the treatment or after the completion of 5 doses of rhTPO, the investigator judged that rhTPO should be continued for treatment, and rhTPO could be administered subcutaneously at 300U/kg/ day for a maximum of 14 doses per cycle. Discontinue when the absolute platelet count increases by ≥50×10\^9/L or when the platelet count rises to ≥250×10\^9/L.
Control
Non-rhTPO treatment
RECRUITING
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
RECRUITING
Beijing Chaoyang District Sanhuan Cancer Hospital, Beijing
RECRUITING
Peking University Shougang Hospital, Beijing
RECRUITING
Chinese PLA General Hospital, Beijing
RECRUITING
Liaoning Cancer Hospital & Institute, Shenyang
RECRUITING
The First Affiliated Hospital of Dalian Medical University, Dalian
RECRUITING
Affiliated Tumor Hospital of Nantong University, Nanyang
RECRUITING
Anqing Municipal Hospital, Anqing
RECRUITING
Tianjin Medical University Cancer Institute and Hospital, Tianjin
RECRUITING
Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan
NOT_YET_RECRUITING
Tongji Hospital Tongji Medical College of Huazhong University of Science & Technology, Wuhan
RECRUITING
Henan Provincial People's Hospital, Zhengzhou
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Shaanxi Provincial Cancer Hospital, Xi'an
NOT_YET_RECRUITING
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Anqing Municipal Hospital
OTHER
Henan Cancer Hospital
OTHER_GOV
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Peking University Shougang Hospital
OTHER
Chinese PLA General Hospital
OTHER
Liaoning Cancer Hospital & Institute
OTHER
Tianjin Medical University Cancer Institute and Hospital
OTHER
Henan Provincial People's Hospital
OTHER
Shaanxi Provincial Cancer Hospital
OTHER
Beijing Sanhuan Cancer Hospital
UNKNOWN
Hebei Medical University Fourth Hospital
OTHER
Tongji Hospital
OTHER
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
OTHER
Bethune Charitable Foundation
UNKNOWN
The First Affiliated Hospital of Dalian Medical University
OTHER